A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity
Status:
Suspended
Trial end date:
2099-01-01
Target enrollment:
Participant gender:
Summary
Many metabolic complications of obesity are a consequence of abnormal responses of the liver,
muscle, and fat to insulin actions. Fenretinide may improve the effects of insulin,
preventing metabolic complications.